European Global Times
SEE OTHER BRANDS

The most trusted news from Europe

European Global Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.

Press releases published on March 24, 2025

Sono Group N.V. and Merlin Solar Technologies Announce Partnership to Expand Global Solar Solutions

Sono Group N.V. and Merlin Solar Technologies Announce Partnership to Expand Global Solar Solutions

MUNICH, Germany, and SAN JOSE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as “Sono Group” or “Sono”, parent company to Sono Motors GmbH or “Sono Motors”) and Merlin Solar …

Syracuse PGI Lemon  Boom in production, but still modest exports

Syracuse PGI Lemon Boom in production, but still modest exports

Production of the yellow citrus fruit grew by 28.7% between 2023 and 2022 and the consumer value by 16.7%. Data from the Ismea - Qualivita 2024 Survey. The LemON project financed by the European Union promotes the lemon also on the foreign markets of …

CMB.TECH and MOL sign landmark agreement for nine ammonia-powered vessels

CMB.TECH and MOL sign landmark agreement for nine ammonia-powered vessels

Antwerp, March 24, 2025 (GLOBE NEWSWIRE) --  CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT …

Rush Factory Oyj on myynyt Saksalaisen tytäryhtiönsä negatiivisella kauppahinnalla

Rush Factory Oyj on myynyt Saksalaisen tytäryhtiönsä negatiivisella kauppahinnalla

Rush Factory Oyj 24.3.2025 klo 11.30 Rush Factory Oyj on myynyt Saksalaisen tytäryhtiönsä negatiivisella kauppahinnalla Rush Factory Oyj on myynyt Saksalaisen tytäryhtiönsä Boninvest Beteiligungen GmbH:lle negatiivisella kauppahinnalla 25.000,00 euroa. …

New Clinical Data on BellaSeno’s Novel, Resorbable Breast Implants Presented at The Aesthetic MEET 2025

New Clinical Data on BellaSeno’s Novel, Resorbable Breast Implants Presented at The Aesthetic MEET 2025

Presentation by Prof. Anand Deva highlights 87% breast volume retention and low complication rate in one-year patient follow-up Successful vascularization and vessel formation in two-year follow-up 3D-printed resorbable scaffold to preserve both volume and …

International Petroleum Corporation Announces Results of Normal Course Issuer Bid

International Petroleum Corporation Announces Results of Normal Course Issuer Bid

TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 246,338 IPC common shares (ISIN: CA46016U1084) during the period …

Philips convenes the Annual General Meeting of Shareholders 2025

Philips convenes the Annual General Meeting of Shareholders 2025

March 24, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes. As previously announced, the agenda …

Bringing fiber to the next billion homes: Nokia automates fiber deployments with Broadband Easy

Bringing fiber to the next billion homes: Nokia automates fiber deployments with Broadband Easy

Press Release Bringing fiber to the next billion homes: Nokia automates fiber deployments with Broadband Easy Nokia Broadband Easy digital platform and services accelerate fiber rollouts by 20%. Advanced automation and AI models make fiber buildouts better …

Hivello Onboards 32,000 Users with Solana Wallets in First HVLO Airdrop

Hivello Onboards 32,000 Users with Solana Wallets in First HVLO Airdrop

LONDON and AMSTERDAM, March 24, 2025 (GLOBE NEWSWIRE) -- Hivello, a DePIN aggregator that enables users to earn by monetizing idle (computing) resources across multiple decentralized networks, has achieved a major milestone with the successful launch of in …

Abivax Announces Full Year 2024 Financial Results

Abivax Announces Full Year 2024 Financial Results

Abivax Announces Full Year 2024 Financial Results •        Cash balance of EUR 144.2M as of December 31, 2024; cash runway into Q4 2025 Full enrollment in Phase 3 ABTECT trial evaluating obefazimod for moderately to severely active ulcerative colitis (“UC …

Decisions of the written procedure of noteholders of AS PRFoods

Decisions of the written procedure of noteholders of AS PRFoods

By a stock exchange announcement published on 06.03.2025, AS PRFoods (registry code 11560713, registered address at Pärnu mnt 141, 11314 Tallinn, Estonia; “PRFoods”) proposed to the persons holding the notes (the “Noteholders”) of PRFoods, due on 31 March …

AS PRFoods võlakirjaomanike kirjaliku hääletamise tulemused

AS PRFoods võlakirjaomanike kirjaliku hääletamise tulemused

06.03.2025 avaldatud  börsiteatega tegi AS PRFoods (registrikood 11560713, aadress Pärnu mnt 141, 11314 Tallinn, Eesti; edaspidi „PRFoods“) ettepaneku isikutele (edaspidi „Võlakirjaomanikud“), kellele kuuluvad PRFoods võlakirjad lunastustähtajaga 31. märts …

Jan Lööfs original i utställning på Bror Hjorths Hus

Jan Lööfs original i utställning på Bror Hjorths Hus

Uppsala, March 24, 2025 (GLOBE NEWSWIRE) -- Jan Lööf - Originalillustrationer (29 mars - 8 juni 2025) på Bror Hjorths Hus, Uppsala Pennstreck och pojkstreck av olika typer - Jan Lööfs originalillustrationer Bror Hjorths Hus visar originalbilder från flera …

Press Release: Availability of the Q1 2025 Aide mémoire

Press Release: Availability of the Q1 2025 Aide mémoire

Availability of the Q1 2025 Aide mémoire Paris, France – March 24, 2025. Sanofi announced today that its Q1 2025 Aide mémoire is available on the "Investors" page of the company's website: First quarter 2025 (sanofi.com) As for each quarter, Sanofi …

Communiqué de presse : Mise en ligne du document « Q1 2025 Aide mémoire »

Communiqué de presse : Mise en ligne du document « Q1 2025 Aide mémoire »

Mise en ligne du document « Q1 2025 Aide mémoire » Paris, France, le 24 mars 2025. Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Q1 2025 Aide mémoire ». Résultats du premier trimestre …

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...

Châtillon, France, March 24, 2025 DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for Biologics License Application (BLA) for Viaskin® Peanut Patch in 4 – 7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H …

DBV Technologies conclut un accord avec la FDA sur les données d'innocuité requises pour la demande de BLA du patch Viaskin® Peanut chez les enfants de 4-7 ans, accélérant ainsi au premier semestre 2026 le dépôt de la demande…

DBV Technologies conclut un accord avec la FDA sur les données d'innocuité requises pour la demande de BLA du patch Viaskin® Peanut chez les enfants de 4-7 ans, accélérant ainsi au premier semestre 2026 le dépôt de la demande…

Châtillon, France, le 24 mars (7h30 CEST) 2024 DBV Technologies conclut un accord avec la FDA sur les données d'innocuité requises pour la demande de licence de produit biologique (BLA) du patch Viaskin® Peanut chez les enfants de 4 à 7 ans, accélérant …

Jeito Capital co-leads the oversubscribed €78 million financing in Augustine Therapeutics to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases

Jeito Capital co-leads the oversubscribed €78 million financing in Augustine Therapeutics to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases

Jeito Capital co-leads the oversubscribed €78 million financing in Augustine Therapeutics to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases Proceeds from the financing will advance Augustine’s lead candidate, AGT …

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing investors Proceeds to support the clinical development of lead …

Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La Réunion with its …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service